products / pediatric gastroenterology / BioGaia Protectis / Lacteeze

BioGaia AB

BioGaia AB is a Swedish biotechnology company and world leader in probiotics with experience and expertise of over 30 years and strong innovation profile.To date, BioGaia AB has in its possession more than 550 patents, commercial presence in more than 100 countries and a natural presence in Europe, USA, China and Japan. BioGaia's vision is peoples' health improvement, by offering probiotic products clinically documented and proven for their safety and effectiveness by age group and by disorder". Until now (2/2020) BioGaia AB has completed more than 217 clinical studies, in babies, children and adults and has proven the safety and efficacy of its probiotic products in several disorders. 

®

BioGaia Protectis

BioGaia Protectis    range of probiotic products contains the most studied - in infants and children - probiotic strain, the patented lactic acid bacterium strain Lactobacillus reuteri  Protectis    (DSM 17938) This extensively studied probiotic strain has been proven to protect from and treat the most common and upsetting functional gastrointestinal disorders in infants (infant colic, constipation and regurgitation) and also the functional abdominal pain in preschool and school aged children. BioGaia Protectis  

®

®

®

has been proven in infants and children, that it maintains a healthier microbiota, reduces the risk of infections and offers an overall better quality of life. It also supports the immune system and helps infants and children with acute gastroenteritis to reduce the associated symptoms and recover faster from diarrhea and vomiting.

Dogs are living species.

But not all are the same.

Breed defines their characteristics.

Probiotics are living species

as well. Strain defines their characteristics!

Click on the picture for more information (currently in Greek only)

Worldwide 1st

​

30 years leading the way of probiotics

First probiotic chewable tablets (2000)

First probiotic drops (2004)

First 3 in 1 ORS (2009)

It's natural

​

We developed the 1st  probiotic of human origin isolated from human breast milk

Multi-action

The probiotic with an excessively studied mode of action and a proven excellent communication and interaction with its host 

Immunity

​

The probiotic that secures a well-functioning microbiota, a tight mucosa and an adequate immune response through a natural and clinically proven mode of action.

Colonisation

The only probiotic with

proven ability to colonize the entire Gastrointestinal Tract. In combination with its multiple mode of action, it offers a solution to a variety of gastrointestinal disorders

Active defence

The only probiotic that produces the well proven, natural, broad spectrum antipathogen factor reuterin

We are born with it 

We developed a probiotic that  is a natural habitat of our  gastrointestinal tract from birth

Gut mobility

The probiotic that improves gut motility by promoting gastric emptying and regulating transit from small and large intestines to favor digestion and promote defecation

Passive defence

​

The probiotic that makes the epithelial lining stronger, tighter and better performing, preventing toxins and pathogens from passing through our digestive system into our body and bloodstream

The most studied 

We isolated, developed, and proved the safety and efficacy of the world's most studied probiotic in pediatric population

Visceral pain

The only probiotic that has been proven to intervene into the gut – brain axis continuous communication in favor of the host, by reducing pain sensation

Even more safe

The probiotic that does not transfer its antibiotic resistance to other bacteria, preventing

from a critical  global  problem, the antibiotic resistance 

Lacteeze

®

Lacteeze   contains lactase enzyme which upon administration allows babies, children and adults with lactose intolerance to digest dairy containing foods again, without suffering from unpleasant symptoms such as bloating, flatulence, abdominal pain and diarrhea. 

Under normal conditions lactase enzyme is produced at the small intestine. It's purpose is to break down lactose (a type of sugar found naturally in the milk of most mammals) so to become digestible. If lactose production in the small intestine is insufficient or absent (a very rare disorder) the digestion is interrupted and lactose 

received through meals becomes an undigestible sugar that triggers a variety of disturbances as such as those described above.

®

WHEN, HOW & WHAT

SHOULD I USE?

I need some more

information

LACTOSE INTOLERANCE 

A PROBLEM FOR 3 OUT OF 10 CHILDREN

Click on the picture for more information (currently in Greek only)